Grants 2022
In 2022 we awarded a total of 550 000 euros in grants to 23 researchers or research groups.
We received 81 grant applications for nearly 2,5 Million Euros. Compared to the previous year, there was an increase in grant applications regarding type 1 diabetes research. A larger amount of funding was also sought for research regarding gestational diabetes. Type 2 diabetes remained the most popular area of study.
Docent Saila Koivusalo from the University of Helsinki was awarded our largest two-year grant of 120 000 euros. She studies fetal programming of child obesity and glucose metabolism disorders.
Professor Marja Vääräsmäki from the University of Oulu received the other large two-year grant of 100 000 euros. Her research group studies gestational diabetes and non-alcoholic fatty liver disease.
Two-year grants, 120 000 and 100 000 euros
Koivusalo Saila, DMSc, docent, HUS and the University of Helsinki, 120 000 euros
Fetal programming of child obesity and glucose metabolism disorders – what is the relevance of a mother’s obesity, pregnancy complications and metabolites of mother and child?
Vääräsmäki Marja, professor, the University of Oulu, THL, 100 000 euros
Non-alcoholic fatty liver disease – incidence and risk factors 10 years after having had gestational diabetes
The grant awarded Vääräsmäki and her research group also contains the following personal grants: Lingaiah Shilpa, 19 600 euros and Torkki Annukka, 16 400 euros.
One-year grants, roughly 27 000 euros
Acosta Manzano Francisco Miguel, PhD., the University of Turku, Turku PET Centre, TYKS, 27 000 euros
Preventing type 2 diabetes by altering the immune profile of brown adipose tissue
Dimova Elitsa, PhD., docent, the University of Oulu, 22 000 euros
Defining the role of transcription factor UFS2 in glucose homeostasis and diabetes in vivo
Dadson Prince, PhD., the University of Turku, Turku PET Centre, 12 500 euros
Studying the role of cholesterol and bile acid metabolism in type 2 diabetes pathogenesis using multiomics
The grant awarded Dadson and his research group also contains the following personal grant: Dadson Prince, 12 500 euros
Juuti-Uusitalo Kati, PhD., docent, the University of Tampere, 27 000 euros
From patient-specific induced stem cells to a type 1 diabetes intestinal model
Lithovius Raija, PhD., the University of Helsinki, Folkhälsan Research Center, 26 000 euros
The adherence to polypharmacy of persons with type 1 diabetes
Moulder Robert, PhD., the University of Turku, 27 000 euros
Classifying Persons with type 1 diabetes through progression rate proteomics
Olkkonen Vesa, PhD., professor, Minerva Research Center, 25 000 euros
GOLM1, a new regulator of hepatocyte and lipocyte metabolism: the implications in non-alcoholic fatty liver disease and type 2 diabetes
The grant awarded Olkkonen and his research group also contains the following personal grant: Chaurasiya Vaishali, 16 000 euros
Pirinen Eija, PhD., assistant professor, the University of Oulu, 27 000 euros
Three-dimensional (3D) cell culture model of human white adipose spheroids – a novel tool for the development of mitochondria activating anti-obesity and anti-diabetic therapy options
Pulkkinen Mari-Anne, MD, the University of Helsinki, 15 000 euros
The bone health of young persons with poor type 1 diabetes care balance – the effects of motivational interviewing on blood sugar balance and bone health
The grant awarded Pulkkinen and her research group also contains the following personal grant: Pulkkinen Mari-Anne, 4 900 euros
Uotila Jukka, MD, docent, the University of Tampere, TAYS, HYKS, TYKS, OYS and KSKS, 23 100 euros
A double-blinded, placebo-controlled multicenter trial focused on using metformin to decrease insulin resistance and improve the prognosis of type 1 diabetes pregnancy
Personal grants, roughly 10 000 euros
Bouslama Rim, M.Sc., the University of Helsinki, 10 000 euros
New inflammation regulation mechanisms in diabetic kidney disease
Hakola Leena, PhD., the University of Tampere, 7 350 euros
Mother and child antibiotic use, and the connection to the development of type 1 diabetes in children
Houttu Noora, M.Sc., the University of Turku, 10 000 euros
Gestation period diet, microflora and low-level inflammation as regulators of a mother’s health: new means of action
Lindfors Sonja, M.Sc., the University of Helsinki, 6 150 euros
The significance of adiponectin signal pathways in the development of diabetes and obesity-related kidney failure
Ranta Amanda, M.Sc., Stanford University, the United States of America, 10 000 euros
Genomics integrating insulin resistance and cardiometabolic risk
Rantala Eeva, M.Sc. (nutritional science), the University of Eastern Finland, 10 000 euros
Workplace selection environments to sustain health and prevent type 2 diabetes: feasibility, acceptability and effectiveness
Taka Antti-Mathias, Lic.Med., the University of Helsinki, 8 200 euros
The effects of genetic disease risk on the manifestation of type 1 diabetes
U-Din Mueez, PhD., the University of Turku, Turku PET Centre, 10 000 euros
Nicotinamide adenine dinucleotide (NAD+) metabolism in human brown adipose tissue
Valta Milla, M.Sc., the University of Turku, 10 000 euros
The immunological mechanisms of type 1 diabetes
Wirkkala Joonas, Lic.Med., the University of Oulu, 6 150 euros
Treatment and follow-up of diabetic retinopathy among type 1 diabetes patients who have undergone a kidney-pancreas transplant
Vuori-Holopainen Nadja, M.Sc., the University of Helsinki, Folkhälsan Research Center, 10 000 euros
A genetic study of diabetic retinopathy